281 related articles for article (PubMed ID: 26259529)
1. Acceptability of, and Information Needs Regarding, Next-Generation Sequencing in People Tested for Hereditary Cancer: A Qualitative Study.
Meiser B; Storey B; Quinn V; Rahman B; Andrews L
J Genet Couns; 2016 Apr; 25(2):218-27. PubMed ID: 26259529
[TBL] [Abstract][Full Text] [Related]
2. Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines.
Marcus RK; Geurts JL; Grzybowski JA; Turaga KK; Clark Gamblin T; Strong KA; Johnston FM
Fam Cancer; 2015 Dec; 14(4):641-9. PubMed ID: 26108897
[TBL] [Abstract][Full Text] [Related]
3. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
4. Consensus document on the implementation of next generation sequencing in the genetic diagnosis of hereditary cancer.
Soto JL; Blanco I; Díez O; García Planells J; Lorda I; Matthijs G; Robledo M; Souche E; Lázaro C
Med Clin (Barc); 2018 Jul; 151(2):80.e1-80.e10. PubMed ID: 29439875
[TBL] [Abstract][Full Text] [Related]
5. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
6. Cancer patients' intentions towards receiving unsolicited genetic information obtained using next-generation sequencing.
Bijlsma RM; Wessels H; Wouters RHP; May AM; Ausems MGEM; Voest EE; Bredenoord AL
Fam Cancer; 2018 Apr; 17(2):309-316. PubMed ID: 28852913
[TBL] [Abstract][Full Text] [Related]
7. Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes: A Focus on Lynch Syndrome and Associated Endometrial Cancer.
Tafe LJ
J Mol Diagn; 2015 Sep; 17(5):472-82. PubMed ID: 26162329
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of laboratory perspectives on hereditary cancer panels.
Stoll J; Weissman SM; Hook N; Selkirk C; Johnson AK; Newlin A; Vogel Postula KJ
Fam Cancer; 2016 Oct; 15(4):689-96. PubMed ID: 26869169
[TBL] [Abstract][Full Text] [Related]
9. [Molecular genetic methods used in diagnosis of hereditary cancers].
Patócs A
Magy Onkol; 2020 Mar; 64(1):25-31. PubMed ID: 32181759
[TBL] [Abstract][Full Text] [Related]
10. Identifying hereditary cancer: genetic counseling and cancer risk assessment.
Lewis KM
Curr Probl Cancer; 2014; 38(6):216-25. PubMed ID: 25432528
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients.
Lincoln SE; Kobayashi Y; Anderson MJ; Yang S; Desmond AJ; Mills MA; Nilsen GB; Jacobs KB; Monzon FA; Kurian AW; Ford JM; Ellisen LW
J Mol Diagn; 2015 Sep; 17(5):533-44. PubMed ID: 26207792
[TBL] [Abstract][Full Text] [Related]
12. Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.
Soukupova J; Zemankova P; Lhotova K; Janatova M; Borecka M; Stolarova L; Lhota F; Foretova L; Machackova E; Stranecky V; Tavandzis S; Kleiblova P; Vocka M; Hartmannova H; Hodanova K; Kmoch S; Kleibl Z
PLoS One; 2018; 13(4):e0195761. PubMed ID: 29649263
[TBL] [Abstract][Full Text] [Related]
13. Gene panel testing for inherited cancer risk.
Hall MJ; Forman AD; Pilarski R; Wiesner G; Giri VN
J Natl Compr Canc Netw; 2014 Sep; 12(9):1339-46. PubMed ID: 25190699
[TBL] [Abstract][Full Text] [Related]
14. Testing for cancer susceptibility genes in children.
Laxova R
Adv Pediatr; 1999; 46():1-40. PubMed ID: 10645460
[TBL] [Abstract][Full Text] [Related]
15. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
16. Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes.
Paulo P; Pinto P; Peixoto A; Santos C; Pinto C; Rocha P; Veiga I; Soares G; Machado C; Ramos F; Teixeira MR
J Mol Diagn; 2017 Jul; 19(4):502-513. PubMed ID: 28529006
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing.
Petersen GM
Hematol Oncol Clin North Am; 2000 Aug; 14(4):939-52. PubMed ID: 10949782
[TBL] [Abstract][Full Text] [Related]
19. Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test.
Nguyen KA; Syed JS; Espenschied CR; LaDuca H; Bhagat AM; Suarez-Sarmiento A; O'Rourke TK; Brierley KL; Hofstatter EW; Shuch B
Cancer; 2017 Nov; 123(22):4363-4371. PubMed ID: 28787086
[TBL] [Abstract][Full Text] [Related]
20. Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.
Kamps R; Brandão RD; Bosch BJ; Paulussen AD; Xanthoulea S; Blok MJ; Romano A
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]